Home / Pharmaceutical / The Pharmaceutical Market: Lebanon

The Pharmaceutical Market: Lebanon

Published: Dec 2014 | No Of Pages: 117 | Published By: Espicom

Product Synopsis

Lebanon Pharmaceuticals & Healthcare Report
 
Although this quarter has seen a number of regulatory initiatives taken by the Lebanese Minister of Health, Ali Hassan Khalil , to improve the state of the pharmaceutical industry, we maintain that a multilateral approach is required to improve foreign direct investment (FDI) in to the country and that , in the short to medium term, investment will be deterred and medical tourism revenue diminished by wider macroeconomic and political vulnerabilit i es. Nonetheless, BMI holds to the view that the country provides stable opportunities for multinationals to tap into the cultural prioritisation for medicines and benefit from the increasingly - urbanized population, although risk s include a relatively weak regulatory framework, poor intellectual property laws and medicine pricing restrictions.
 
Headline Expenditure Projections
  • Pharmaceuticals: LBP1,959bn (US$1.30bn) in 2011 to LBP2,061bn (US$1.37bn) in 2012; +8.6% in local currency terms and +9.2% in US dollar terms. Forecastrevised upwards from Q4 12 due to modifications to historical figures.
  • Healthcare: LBP4,495bn (US$2.99bn) in 2011 to LBP4,750bn (US$3.15bn) in 2012; +5.7% in local currency terms and +5.6% in US dollar terms. Forecastrevised upwards from Q4 12 due to modifications to historical figures.
  • Medical Devices: LBP365.26bn (US$243mn) in 2011 to LBP402.84bn (US$267mn) in 2012; +10.3% in local currency terms and +10.2% in US dollar terms. Forecastrevised downwards from Q4 12 due to modifications to historical figures.
Competitive Landscape
 
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
BMI Industry View7
SWOT9
Political11
Economic12
Business Environment13
Industry Forecast14
Pharmaeutical Market Forecast14
 
Table: Pharmaceutical Sales, Historical Data And Forecasts (Lebanon 2010-2018)16
 
Healthcare Market Forecast17
 
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2010-2018)18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2010-2018)19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Lebanon 2010-2018)20
 
Prescription Drug Market Forecast21
 
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Lebanon 2010-2018)22
 
Patented Drug Market Forecast23
 
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Lebanon 2010-2018)24
 
Generic Drug Market Forecast25
 
Table: Generics Drug Market Indicators, Historical Data And Forecasts (Lebanon 2010-2018)27
 
OTC Medicine Market Forecast28
 
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Lebanon 2010-2018)29
 
Pharmaceutical Trade Forecast30
 
Table: Pharmaceutical Trade Data And Forecasts (Lebanon 2012-2018)32
Table: Pharmaceutical Trade Data And Forecasts local currency (Lebanon 2012-2018)33
 
Other Healthcare Data33
Key Risks To BMI's Forecast Scenario34
Macroeconomic Forecasts36
Economic Outlook36
 
Table: Lebanon - Economic Activity46
 
Industry Risk Reward Ratings47
Middle East & Africa Risk/Reward Ratings47
Lebanon Risk/Reward Ratings55
Rewards55
Risks55
Market Overview57
Industry Trends And Developments58
Epidemiology58
Healthcare Sector60
Healthcare Insurance61
Medical Tourism64
Regional Healthcare Collaboration65
Clinical Trials66
Regulatory Development67
Regulatory Developments68
Counterfeit Drugs69
Public Sector Procurement69
Intellectual Property Regime70
Free Trade Agreements72
Pricing Regime72
Reimbursement Regime74
Competitive Landscape75
Pharmaceutical Sector75
Pharmaceutical Sector Developments76
Pharmaceutical Distribution77
Retail Pharmacy Sector78
Company Profile79
Benta Pharnaceutical Industries (BPI)79
Pharmaline81
Chalhoub Pharmaceuticals (CHAPHA)83
Alfa Laboratories85
Algorithm87
Codipha90
Pfizer92
Novartis94
Merck & Co96
Johnson & Johnson (J&J)98
Sanofi100
GlaxoSmithKline (GSK)102
Abbott Laboratories104
Demographic Forecast106
 
Table: Lebanon's Population By Age Group, 1990-2020 ('000)107
Table: Lebanon's Population By Age Group, 1990-2020 (% of total)108
Table: Lebanon's Key Population Ratios, 1990-2020109
Table: Lebanon's Rural And Urban Population, 1990-2020109
 
Glossary110
Methodology112
Pharmaceutical Expenditure Forecast Model112
Healthcare Expenditure Forecast Model112
Notes On Methodology113
Risk/Reward Ratings Methodology114
Ratings Overview115
 
Table: Pharmaceutical Risk/Reward Ratings Indicators115
 
Indicator Weightings116
Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +